• Adults taking Foundayo lost an average of 27 pounds on the highest dose in …
Tag:
Eli Lilly and Company (NYSE: LLY)
-
-
Lifestyle & Healthslider
Lilly’s Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer’s disease
by Karine Ayoubby Karine AyoubFindings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla continued to demonstrate slowing …